The United States plans to launch a large-scale information campaign against the Russian Sputnik V coronavirus vaccine. Reports about this of practically the same content with reference to an anonymous "high-ranking source in the Kremlin" were simultaneously disseminated by the largest news agencies TASS, RIA Novosti and Interfax, writes Kommersant.
"Against the background of the growing demand for the Russian Sputnik V vaccine around the world, including in European countries, the United States and its allies, according to our intelligence services, are planning to launch a large-scale information campaign aimed at creating a bias towards domestic scientific developments to counteract the spread of Covid-19", the message reads.
It is noted that the campaign will target European countries that have registered the Sputnik V coronavirus vaccine, in particular Hungary, Slovakia, Serbia, Montenegro, San Marino and North Macedonia. In addition, it is planned to stage the mass death of people allegedly as a result of the use of "Sputnik V", the source claims.
An information attack is being prepared allegedly through nongovernmental organizations - the US Agency for International Development, J. Soros Foundation, Thomson Reuters Foundation, as well as through a number of media - BBC, Reuters, Internews. The source did not specify the start time of the campaign.
According to intelligence agencies, the campaign aims to undermine confidence in Sputnik V.
"A scenario is being prepared for an information attack on Sputnik V, within the framework of which it is planned to reinforce the promoted theses about the" ineffectiveness and danger of the vaccine "by staging mass deaths of people allegedly as a result of the use of the drug," news agencies say.
They also argue that "such actions by the United States and its allies testify to their attempts to belittle the contribution of Russian science to the global fight against the spread of Covid-19, undermine the confidence of the world community in its scientific developments and prevent them from being certified by WHO, as well as reduce foreign demand for the vaccine.